Pain Medication Management Before Cardiac Catheterization
Most pain medications do not need to be stopped before cardiac catheterization, with the critical exception of NSAIDs and antiplatelet agents, which require specific timing considerations based on bleeding risk and cardiac indication.
Key Medication Categories and Management
Opioid Analgesics - Continue
- Opioid pain medications (morphine, oxycodone, hydrocodone, fentanyl) should be continued through the morning of cardiac catheterization 1, 2
- Medications for chronic pain need to be continued on the morning of surgery and should be prescribed in the postoperative period 2
- Morphine (3-5 mg IV or subcutaneously) is specifically listed as a primary therapeutic measure during acute coronary syndromes and can be administered depending on pain severity 1
Buprenorphine - Continue with Modifications
- Patients on buprenorphine for opioid use disorder or pain should generally continue their medication perioperatively 3
- For patients taking ≤12 mg sublingual buprenorphine, continue through the perioperative period 3
- For patients on higher doses, consider tapering to 12 mg sublingual 2-3 days before the procedure 3
- Multimodal analgesia and regional techniques should be employed where possible 3
NSAIDs - Exercise Caution
- NSAIDs should be avoided in patients with preexisting renal disease, congestive heart failure, or cirrhosis to prevent acute renal failure 4
- NSAIDs have antiplatelet effects and should be considered in the perioperative setting 4
- Ibuprofen should be stopped for two days before surgery, naproxen for 2-3 days 4
- The FDA issued a black box warning for all NSAIDs (except aspirin) immediately after CABG due to increased cardiovascular events and sternal infections 5
Aspirin - Context-Dependent
- For patients with recent myocardial infarction or recent cardiac stent placement, aspirin should be continued before and after the procedure 4
- For diagnostic cardiac catheterization without acute coronary syndrome, aspirin continuation depends on cardiovascular risk versus bleeding risk 4
- If aspirin must be withheld preoperatively, it should be stopped 7-10 days before surgery 4
P2Y12 Inhibitors (Clopidogrel, Ticagrelor, Prasugrel) - Timing Critical
- For elective procedures, clopidogrel and ticagrelor should be discontinued at least 5 days before surgery, and prasugrel at least 7 days before 6
- For urgent procedures, these agents should be discontinued for at least 24 hours to reduce major bleeding 6
- The timing must balance bleeding risk against thrombotic risk, particularly in patients with drug-eluting stents placed within 6 months to 1 year 7
Procedural Sedation Medications
- Benzodiazepines and opioids used for procedural sedation during cardiac catheterization are safe and effective when used with appropriate monitoring 8
- These medications modestly reduce pain and anxiety, improve patient tolerability, and reduce risk of radial artery spasm 8
- Important caveat: Opioid medications reduce the absorption of loading doses of oral antiplatelet drugs, which is relevant if clopidogrel or other P2Y12 inhibitors need to be loaded during the procedure 8
Common Pitfalls to Avoid
- Do not stop chronic opioid pain medications before cardiac catheterization - this increases patient discomfort without improving safety 1, 2
- Do not assume all "pain medications" are the same - NSAIDs carry renal and cardiovascular risks that opioids do not 4, 5
- Do not continue P2Y12 inhibitors without assessing stent timing and urgency - recent stent placement (<6-12 months) dramatically increases thrombotic risk if these are stopped 7, 6
- Do not use NSAIDs for perioperative analgesia in cardiac patients - the cardiovascular and bleeding risks outweigh benefits 5